These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 25176115)

  • 1. Posttreatment drug use abstinence: does the majority program clientele matter?
    Duncan A; Melnick G; Ahmed R; Furr-Holden CD
    J Ethn Subst Abuse; 2014; 13(3):185-208. PubMed ID: 25176115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Client and program characteristics associated with wait time to substance abuse treatment entry.
    Andrews CM; Shin HC; Marsh JC; Cao D
    Am J Drug Alcohol Abuse; 2013 Jan; 39(1):61-8. PubMed ID: 22783953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial disparities in substance abuse treatment and the ecological fallacy.
    Melnick G; Duncan A; Thompson A; Wexler HK; Chaple M; Cleland CM
    J Ethn Subst Abuse; 2011; 10(3):226-45. PubMed ID: 21888500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Program structure and counselor-client contact in outpatient substance abuse treatment.
    Knight DK; Broome KM; Simpson DD; Flynn PM
    Health Serv Res; 2008 Apr; 43(2):616-34. PubMed ID: 18370970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How can we help African American substance users stop smoking? client and agency perspectives.
    Berman BA; Jones L; Jones F; Jones A; Pacheco BA; McCarthy WJ
    J Ethn Subst Abuse; 2019; 18(3):428-444. PubMed ID: 29257942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of long-term residential substance abuse treatment for women: findings from three national studies.
    Greenfield L; Burgdorf K; Chen X; Porowski A; Roberts T; Herrell J
    Am J Drug Alcohol Abuse; 2004 Aug; 30(3):537-50. PubMed ID: 15540492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Organizational- and individual-level correlates of posttreatment substance use: a multilevel analysis.
    Ghose T
    J Subst Abuse Treat; 2008 Mar; 34(2):249-62. PubMed ID: 17600654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Organizational and client determinants of cost in outpatient substance abuse treatment.
    Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
    J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment staff's continuity of care practices, patients' engagement in continuing care, and abstinence following outpatient substance-use disorder treatment.
    Schaefer JA; Harris AH; Cronkite RC; Turrubiartes P
    J Stud Alcohol Drugs; 2008 Sep; 69(5):747-56. PubMed ID: 18781250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complementary treatment of drug addicts in Malaysia.
    Razali SM
    Trop Doct; 2000 Apr; 30(2):105-6. PubMed ID: 10842562
    [No Abstract]   [Full Text] [Related]  

  • 11. Perceived coercion among clients entering substance abuse treatment: structural and psychological determinants.
    Wild TC; Newton-Taylor B; Alletto R
    Addict Behav; 1998; 23(1):81-95. PubMed ID: 9468745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gender disparities in utilization and outcome of comprehensive substance abuse treatment among racial/ethnic groups.
    Guerrero EG; Marsh JC; Cao D; Shin HC; Andrews C
    J Subst Abuse Treat; 2014; 46(5):584-91. PubMed ID: 24560127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of organizational functioning on client engagement in treatment.
    Greener JM; Joe GW; Simpson DD; Rowan-Szal GA; Lehman WE
    J Subst Abuse Treat; 2007 Sep; 33(2):139-47. PubMed ID: 17433863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Client Engagement in Legally-Mandated Addiction Treatment: A Prospective Study Using Self-Determination Theory.
    Wild TC; Yuan Y; Rush BR; Urbanoski KA
    J Subst Abuse Treat; 2016 Oct; 69():35-43. PubMed ID: 27568508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leadership, burnout, and job satisfaction in outpatient drug-free treatment programs.
    Broome KM; Knight DK; Edwards JR; Flynn PM
    J Subst Abuse Treat; 2009 Sep; 37(2):160-70. PubMed ID: 19339143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Client-Provider relationship in comprehensive substance abuse treatment: differences in residential and nonresidential settings.
    Shin HC; Marsh JC; Cao D; Andrews CM
    J Subst Abuse Treat; 2011 Dec; 41(4):335-46. PubMed ID: 21871770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of organization and management in private and public substance abuse treatment programs.
    Roman PM; Ducharme LJ; Knudsen HK
    J Subst Abuse Treat; 2006 Oct; 31(3):235-43. PubMed ID: 16996386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Program variation in treatment outcomes among women in residential drug treatment.
    Grella CE; Joshi V; Hser YI
    Eval Rev; 2000 Aug; 24(4):364-83. PubMed ID: 11009864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Constructive conflict and staff consensus in substance abuse treatment.
    Melnick G; Wexler HK; Chaple M; Cleland CM
    J Subst Abuse Treat; 2009 Mar; 36(2):174-82. PubMed ID: 18657943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The contribution of consensus within staff and client groups as well as concordance between staff and clients to treatment engagement.
    Melnick G; Wexler HK; Chaple M; Banks S
    J Subst Abuse Treat; 2006 Oct; 31(3):277-85. PubMed ID: 16996390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.